Status:
RECRUITING
Sleep and Neuropathic Pain - Intervention Study on Pregabalin
Lead Sponsor:
Helsinki University Central Hospital
Collaborating Sponsors:
University of Helsinki
Conditions:
Neuropathic Pain
Insomnia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The goal of this clinical study is to study sleep and its microstructure in neuropathic pain patients who have or who do not have a clinically significant sleep disturbance, before and during (after 1...
Detailed Description
This is a clinical study to analyze sleep and pain and their response to pregabalin in 40 patients aged 18 to 75 years with chronic (duration\>3 months) moderate to severe pain (NRS ≥ 4/10) due to per...
Eligibility Criteria
Inclusion
- Chronic (duration \> 3 months) painful peripheral neuropathy
- Pain moderate to severe (NRS ≥ 4/10) during the past week
Exclusion
- psychotic depression, clinically significant bipolar disorder
- contraindication for performing brain fMRI (metal in the body etc)
Key Trial Info
Start Date :
November 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06155916
Start Date
November 22 2022
End Date
December 1 2026
Last Update
March 14 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Central Hospital
Helsinki, HUS, Finland, 00029
2
Helsinki University Hospital, Department of Neurology
Helsinki, Uusimaa, Finland, 00029